BioCentury | Dec 19, 2005
Company News

Cytori management update

...John Ransom as VP of research for regenerative cell technology, formerly VP of biology at Novasite Pharmaceuticals Inc. WIR...
BioCentury | Jun 27, 2005
Emerging Company Profile

Corporate Profile

Novasite Pharmaceuticals Inc. San Diego, Calif. Technology: Allosteric modulation of GPCRs Disease focus: Neurology Clinical status: Preclinical Founded: 2000 by Juan Ballesteros, Michael Freedman and William Huse, as a spinout from Applied Molecular Evolution Inc....
BioCentury | Jun 27, 2005
Emerging Company Profile

Novasite: Conceptually quick

...difficult, due to the challenges of detecting the activity of such compounds in a screen. Novasite Pharmaceuticals Inc....
BioCentury | Jun 20, 2005
Company News

Novasite Pharmaceuticals management update

Novasite Pharmaceuticals Inc. , San Diego, Calif. Business: Neurology Hired: James Hauske as EVP of drug discovery, formerly president and CEO of PsyCheNomicS Inc., which Novasite acquired WIR Staff Neurology...
BioCentury | Jun 20, 2005
Company News

Novasite Pharmaceuticals, PsyCheNomicS Inc. deal

...Novasite, which develops allosteric modulators of GPCRs, said the deal gives it CNS therapeutic leads. Novasite Pharmaceuticals Inc....
BioCentury | Jun 13, 2005
Company News

Novasite Pharmaceuticals management update

Novasite Pharmaceuticals Inc. , San Diego, Calif. Business: Computational chemistry/biology Hired: Tim Harris as president and CEO, formerly CEO of Structural GenomiX Inc. WIR Staff...
BioCentury | Feb 21, 2005
Company News

Novasite Pharmaceuticals, OriGene deal

...Collection of 24,000 full-length human cDNAs for use in transfection and high throughput functional analyses. Novasite Pharmaceuticals Inc....
BioCentury | Dec 13, 2004
Company News

Novasite Pharmaceuticals scientific advisory board update

Novasite Pharmaceuticals Inc. , San Diego, Calif. Business: Neurology Appointed: Michael Knable, executive director of the Stanley Medical Research Institute; and John Davis, a director of the Stanley Medical Research Institute scientific advisory board WIR Staff...
BioCentury | Dec 13, 2004
Company News

Novasite Pharmaceuticals, The Stanley Medical Research Institute deal

...aims to discover allosteric modulators that act on a validated G protein-coupled receptor (GPCR) target. Novasite Pharmaceuticals Inc....
BioCentury | Apr 8, 2002
Company News

Applied Molecular other research news

...AMEV subsidiary Novasite Pharmaceuticals Inc. received a 2-year $2.4 million Phase II SBIR grant from the National Institute...
Items per page:
1 - 10 of 14
BioCentury | Dec 19, 2005
Company News

Cytori management update

...John Ransom as VP of research for regenerative cell technology, formerly VP of biology at Novasite Pharmaceuticals Inc. WIR...
BioCentury | Jun 27, 2005
Emerging Company Profile

Corporate Profile

Novasite Pharmaceuticals Inc. San Diego, Calif. Technology: Allosteric modulation of GPCRs Disease focus: Neurology Clinical status: Preclinical Founded: 2000 by Juan Ballesteros, Michael Freedman and William Huse, as a spinout from Applied Molecular Evolution Inc....
BioCentury | Jun 27, 2005
Emerging Company Profile

Novasite: Conceptually quick

...difficult, due to the challenges of detecting the activity of such compounds in a screen. Novasite Pharmaceuticals Inc....
BioCentury | Jun 20, 2005
Company News

Novasite Pharmaceuticals management update

Novasite Pharmaceuticals Inc. , San Diego, Calif. Business: Neurology Hired: James Hauske as EVP of drug discovery, formerly president and CEO of PsyCheNomicS Inc., which Novasite acquired WIR Staff Neurology...
BioCentury | Jun 20, 2005
Company News

Novasite Pharmaceuticals, PsyCheNomicS Inc. deal

...Novasite, which develops allosteric modulators of GPCRs, said the deal gives it CNS therapeutic leads. Novasite Pharmaceuticals Inc....
BioCentury | Jun 13, 2005
Company News

Novasite Pharmaceuticals management update

Novasite Pharmaceuticals Inc. , San Diego, Calif. Business: Computational chemistry/biology Hired: Tim Harris as president and CEO, formerly CEO of Structural GenomiX Inc. WIR Staff...
BioCentury | Feb 21, 2005
Company News

Novasite Pharmaceuticals, OriGene deal

...Collection of 24,000 full-length human cDNAs for use in transfection and high throughput functional analyses. Novasite Pharmaceuticals Inc....
BioCentury | Dec 13, 2004
Company News

Novasite Pharmaceuticals scientific advisory board update

Novasite Pharmaceuticals Inc. , San Diego, Calif. Business: Neurology Appointed: Michael Knable, executive director of the Stanley Medical Research Institute; and John Davis, a director of the Stanley Medical Research Institute scientific advisory board WIR Staff...
BioCentury | Dec 13, 2004
Company News

Novasite Pharmaceuticals, The Stanley Medical Research Institute deal

...aims to discover allosteric modulators that act on a validated G protein-coupled receptor (GPCR) target. Novasite Pharmaceuticals Inc....
BioCentury | Apr 8, 2002
Company News

Applied Molecular other research news

...AMEV subsidiary Novasite Pharmaceuticals Inc. received a 2-year $2.4 million Phase II SBIR grant from the National Institute...
Items per page:
1 - 10 of 14